pre-IPO PHARMA

COMPANY OVERVIEW

Petra Pharma is a drug development company focused on novel enzyme targets that play a central role in a variety of important cellular processes, including cell division, growth, trafficking, and signaling. Petra Pharma is developing novel small molecules for the treatment of cancer and metabolic diseases to target these cellular processes in order to therapeutically impact human health.


LOCATION

  • New York, NY, USA

  • THERAPEUTIC AREAS

  • Metabolic Disorders
  • Oncology

  • WEBSITE

    https://petrapharmacorp.com/


    CAREER WEBSITE

    https://petrapharmacorp.com/careers/


    SOCIAL MEDIA


    INVESTORS

    180-captial-corp abbvie-ventures alexandria-venture-investments arch-venture-partners innovate-ny-fund jjdc lilly-ventures partnership-for-new-york-city pfizer-ventures watson-fund wuxi-apptec


    PRESS RELEASES


    Apr 2, 2019

    Petra Pharma Strengthens Management Team With Recent Leadership Appointments


    Mar 20, 2019

    Petra Pharma announces licensing agreement with Takeda Pharmaceutical Company


    Dec 1, 2018

    Petra Pharma Presents Preclinical PIP4K2 Inhibitor Data as a Potential Treatment for Hematologic Malignancies at the 2018 American Society of Hematology Annual Meeting


    Apr 11, 2018

    Evotec Forms Collaboration with Petra Pharma on Indigo Platform


    Sep 19, 2017

    Petra Pharma and Schrödinger Announce Research Collaboration


    For More Press Releases


    Google Analytics Alternative